Aryl Hydrocarbon Receptor Activation in Astrocytes by Laquinimod Ameliorates Autoimmune Inflammation in the CNS

Conclusions Taken together, these findings suggest that AHR activation by clinically relevant AHR agonists may represent a novel therapeutic approach for the treatment of MS.

http://nn.neurology.org/cgi/content/short/8/2/e946?rss=1

Source: Neurology Neuroimmunology and Neuroinflammation - January 6, 2021 Category: Neurology Authors: Rothhammer, V., Kenison, J. E., Li, Z., Tjon, E., Takenaka, M. C., Chao, C.-C., Alves de Lima, K., Borucki, D. M., Kaye, J., Quintana, F. J. Tags: Multiple sclerosis Article Source Type: research